OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients
Arrigo F.G. Cicero, Federica Fogacci, Raffaele Ivan Cincione, et al.
Medical Principles and Practice (2020) Vol. 30, Iss. 2, pp. 122-130
Open Access | Times Cited: 77
Arrigo F.G. Cicero, Federica Fogacci, Raffaele Ivan Cincione, et al.
Medical Principles and Practice (2020) Vol. 30, Iss. 2, pp. 122-130
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
Arrigo F.G. Cicero, Federica Fogacci, Masanari Kuwabara, et al.
Medicina (2021) Vol. 57, Iss. 1, pp. 58-58
Open Access | Times Cited: 79
Arrigo F.G. Cicero, Federica Fogacci, Masanari Kuwabara, et al.
Medicina (2021) Vol. 57, Iss. 1, pp. 58-58
Open Access | Times Cited: 79
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 42
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 42
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 35
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 35
Gout therapeutics and drug delivery
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 28
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 28
Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA
Mengjie Zhang, Abid Hussain, Bo Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Mengjie Zhang, Abid Hussain, Bo Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach
Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 102-102
Open Access | Times Cited: 1
Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 102-102
Open Access | Times Cited: 1
Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Chemical Composition, In Vitro and In Silico Antioxidant Potential of Melissa officinalis subsp. officinalis Essential Oil
Matilda Rădulescu, Călin Jianu, Alexandra Teodora Lukinich-Gruia, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1081-1081
Open Access | Times Cited: 46
Matilda Rădulescu, Călin Jianu, Alexandra Teodora Lukinich-Gruia, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1081-1081
Open Access | Times Cited: 46
Review of Urate-Lowering Therapeutics: From the Past to the Future
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases
Vagish Dwibedi, Sahil Jain, Divya Singhal, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 4, pp. 1399-1417
Closed Access | Times Cited: 33
Vagish Dwibedi, Sahil Jain, Divya Singhal, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 4, pp. 1399-1417
Closed Access | Times Cited: 33
Ethanolic Extract from Limonia acidissima L. Fruit Attenuates Serum Uric Acid Level via URAT1 in Potassium Oxonate-Induced Hyperuricemic Rats
Rika Yusnaini, Rosnani Nasution, Nurdin Saidi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 419-419
Open Access | Times Cited: 18
Rika Yusnaini, Rosnani Nasution, Nurdin Saidi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 419-419
Open Access | Times Cited: 18
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease
Hunter Korsmo, Ubong S. Ekperikpe, Ilse S. Daehn
Antioxidants (2024) Vol. 13, Iss. 6, pp. 712-712
Open Access | Times Cited: 7
Hunter Korsmo, Ubong S. Ekperikpe, Ilse S. Daehn
Antioxidants (2024) Vol. 13, Iss. 6, pp. 712-712
Open Access | Times Cited: 7
The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems
Davide Agnoletti, Arrigo F.G. Cicero, Claudio Borghi
Cardiology Clinics (2021) Vol. 39, Iss. 3, pp. 365-376
Closed Access | Times Cited: 35
Davide Agnoletti, Arrigo F.G. Cicero, Claudio Borghi
Cardiology Clinics (2021) Vol. 39, Iss. 3, pp. 365-376
Closed Access | Times Cited: 35
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
Thomas Bais, Ron T. Gansevoort, Esther Meijer
Drugs (2022) Vol. 82, Iss. 10, pp. 1095-1115
Open Access | Times Cited: 26
Thomas Bais, Ron T. Gansevoort, Esther Meijer
Drugs (2022) Vol. 82, Iss. 10, pp. 1095-1115
Open Access | Times Cited: 26
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
Slobodan Rendić, Rachel D. Crouch, F. Peter Guengerich
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2145-2246
Open Access | Times Cited: 25
Slobodan Rendić, Rachel D. Crouch, F. Peter Guengerich
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2145-2246
Open Access | Times Cited: 25
Xanthine oxidase inhibitory study of eight structurally diverse phenolic compounds
Arshad Mehmood, Jiayi Li, Ashfaq Ur Rehman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 25
Arshad Mehmood, Jiayi Li, Ashfaq Ur Rehman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 25
Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
R. Foti
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 936-949
Open Access | Times Cited: 15
R. Foti
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 936-949
Open Access | Times Cited: 15
Research Progress on New Functions of Animal and Plant Proteins
Hao Duan, Gaigai Liu, Duo Feng, et al.
Foods (2024) Vol. 13, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 5
Hao Duan, Gaigai Liu, Duo Feng, et al.
Foods (2024) Vol. 13, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 5
Microneedle transdermal drug delivery as a candidate for the treatment of gouty arthritis: Material structure, design strategies and prospects
Yi Hong, Haojie Yu, Li Wang, et al.
Acta Biomaterialia (2024) Vol. 187, pp. 20-50
Closed Access | Times Cited: 5
Yi Hong, Haojie Yu, Li Wang, et al.
Acta Biomaterialia (2024) Vol. 187, pp. 20-50
Closed Access | Times Cited: 5
Association of hyperuricemia with cardiovascular diseases: current evidence
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Song Ke, Ming He, Xiangxin Kong, et al.
BMC Surgery (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Song Ke, Ming He, Xiangxin Kong, et al.
BMC Surgery (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Eurycomanol alleviates hyperuricemia by promoting uric acid excretion and reducing purine synthesis
Ruixia Bao, Qian Chen, Zheng Li, et al.
Phytomedicine (2021) Vol. 96, pp. 153850-153850
Closed Access | Times Cited: 27
Ruixia Bao, Qian Chen, Zheng Li, et al.
Phytomedicine (2021) Vol. 96, pp. 153850-153850
Closed Access | Times Cited: 27
Vascular actions of Ang 1-7 and Ang 1-8 through EDRFs and EDHFs in non-diabetes and diabetes mellitus
Nazar M. Shareef Mahmood, Almas M. R. Mahmud, Ismail M. Maulood
Nitric Oxide (2025) Vol. 156, pp. 9-26
Closed Access
Nazar M. Shareef Mahmood, Almas M. R. Mahmud, Ismail M. Maulood
Nitric Oxide (2025) Vol. 156, pp. 9-26
Closed Access
Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study
Mohammed Er-rajy, Mohamed El fadili, Sara Zarougui, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Mohammed Er-rajy, Mohamed El fadili, Sara Zarougui, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
The role of oxidative disorders in the pathogenesis of kidney damage in type 1 diabetes mellitus and diabetic nephropathy in children: xanthine oxidase as a trigger
Євгенія Бурлака, Ihor V. Kovalchuk, I.O. Mityuryayeva-Kornijko
Polski Merkuriusz Lekarski (2025) Vol. 53, Iss. 1, pp. 108-114
Closed Access
Євгенія Бурлака, Ihor V. Kovalchuk, I.O. Mityuryayeva-Kornijko
Polski Merkuriusz Lekarski (2025) Vol. 53, Iss. 1, pp. 108-114
Closed Access
